11-5227019-C-T
Variant summary
Our verdict is Pathogenic. Variant got 20 ACMG points: 20P and 0B. PVS1PS1_ModeratePM2PP5_Very_Strong
The NM_000518.5(HBB):c.3G>A(p.Met1?) variant causes a start lost change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000518.5 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 26
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Beta zero thalassemia Pathogenic:1
- -
not specified Pathogenic:1
- -
Dominant beta-thalassemia Pathogenic:1
Variant summary: HBB c.3G>A alters the initiation codon (therefore the predicted protein level name is p.Met1Ile) and is expected to result either in absence of the protein or truncation of the encoded protein due to translation initiation at a downstream codon. The variant was absent in 251128 control chromosomes (gnomAD). c.3G>A has been reported in the literature in multiple individuals in the heterozygous state, who had hematologic findings characteristic for Beta Thalassemia Minor (Saba_1991, Landin_1995, Vetter_1997), in addition, one of the reported heterozygous individuals had child(ren) with transfusion-dependent thalassemia (Hussain_2017). These data indicate that the variant in homozygosity and/or compound heterozygosity with a severe variant, is likely to cause the BTHAL MJR phenotype. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Other variants affecting the initiation codon (e.g. c.1A>G, c.2T>G, c.2T>C) have been classified as pathogenic by our laboratory. Three submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and all classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
beta Thalassemia Pathogenic:1
- -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at